SAN DIEGO, CA / ACCESS Newswire / April 6, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or ...

Cohealyx® multi-center study interim analysis and new case data to be presentedRECELL® and PermeaDerm® data reinforce a comprehensive approach to wound healingEvidence demonstrates potential to ...

For stabilized AMI without left ventricular systolic dysfunction or HF, discontinuing β-blockers after 1 year or longer is noninferior to continuing it.

Nationally, there has been a rise in the number of children and adolescents with congenital and acquired heart disease ...

Rapid testing identifies acute respiratory distress syndrome subtypes linked to mortality, supporting precision medicine in ...

Disclosure forms provided by the author are available with the full text of this editorial at NEJM.org. Ary Serpa Neto, M.D., Ph.D. Australian and New Zealand Intensive Care Research Centre, School of ...

The newest hospital at UC San Diego Health is delivering world-class care through a unique service model led by physicians, nurses and staff.

Aid groups are warning that the war in the Middle East has upended their ability to get food and medicine to millions in need ...

Two years after purchasing the struggling college-area hospital, UC San Diego Health is more than doubling its investment in ...

Route 92 Medical announced today that it secured $50 million in growth financing to support its neurovascular intervention offerings.

The war in Iran has slowed down international shipping, much of which contains medical and humanitarian goods destined for ...

Coronary artery disease (CAD) is the leading cause of death worldwide, with acute myocardial infarction (MI) representing the ...